The Value of Placental Vascularization and Placental Volume in Pregnancy in APLS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-04-24

Study Completion Date

2020-10-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Antiphospholipid antibodies are autoantibodies directed against phospholipid-binding proteins. Among these groups of antibodies, lupus anticoagulant (LA) and anticardiolipin antibodies (aCL)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ultrasound in Prediction of Operative Findings in Cesarean Section Among Placenta Accreta Cases

NCT03286998

Placenta Accreta Placenta Previa

UNKNOWN

Pulmonary Artery Doppler and Neonatal Outcome in Placenta Accreta Spectrum Patients

NCT04911322

Placenta Accreta

COMPLETED

Diagnostic Accuracy of a Specialized Pro Forma in Assessing Morbidly Adherent Placenta With Correlation to Intra-operative Findings

NCT04938050

Morbidly Adherent Placenta

UNKNOWN

Diagnostic Accuracy of Placental Thickness in Lower Uterine Segment Measured By Ultrasound in Prediction of Placenta Accreta Spectrum in Patients With Placenta Previa. A Diagnostic Test Accuracy Study

NCT05500404

Placenta Accreta Spectrum

COMPLETED

Surgical Classification of Abnormal Placentation

NCT02736058

Adherent Placenta

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

APLS can be primary when no evidence of autoimmune disease is found, or secondary to autoimmune processes like systemic lupus erythematous (SLE) in a 40% of the cases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Antiphospholipid Syndrome in Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

antiphospholipid group

pregnant ladies in the third trimester who have antiphospholipid syndrome

Ultrasound with Doppler and 3D technology

Intervention Type DIAGNOSTIC_TEST

ultrasound will be made to pregnant females in 3rd trimester with doppler and 3D technology

control group

pregnant ladies in the third trimester who have no medical disorders with pregnancy

Ultrasound with Doppler and 3D technology

Intervention Type DIAGNOSTIC_TEST

ultrasound will be made to pregnant females in 3rd trimester with doppler and 3D technology

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound with Doppler and 3D technology

ultrasound will be made to pregnant females in 3rd trimester with doppler and 3D technology

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Singleton pregnancy.

* Gestational age of 34-37 weeks.
* Pregnant women with antiphospholipid syndrome

Exclusion Criteria

* Twin or multiple pregnancies.
* Congenital fetal anomalies.
* Gestational age of less than 34.
* Gestational age of more than 37.
* Women with placental or umbilical artery anomalies.
* Antepartum hemorrhage (placental abruption, placenta previa and vasa previa).
* Posterior placenta.
* History of rupture of membrane.
* Patient refusal or fall outs.

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes